Citi analyst Joanne Wuensch raised the firm’s price target on Medtronic (MDT) to $99 from $98 and keeps a Buy rating on the shares. The firm adjusted targets in medical technology as part of a Q2 earnings preview.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Medtronic appoints Spooner as CFO of MiniMed
- KKR, Medtronic, Disney, Circle, Barrick: Trending by Analysts
- Medtronic’s Loop Recorder Study: A Potential Game-Changer in Cardiac Diagnostics
- Medtronic’s Care-HF Study: A Milestone in Cardiac Resynchronization Therapy
- Medtronic’s CORE Study Update: Evaluating the Conducted AF-Response Algorithm